Bristol-Myers Squibb
(NYSE:BMY)
$48.45
-0.06[-0.12%]
Last update: 10:48AM Get Real Time Here
Q1 2024 Earnings in 9 days from now on Thu Apr 25th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
66
0100
Financials Analysis
60
0100

Bristol-Myers Squibb Stock (NYSE:BMY), Quotes and News Summary

Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.

Open$48.450
Close-
Volume / Avg.1.988M / 15.931M
Day Range48.240 - 48.585
52 Wk Range47.580 - 70.935
Market Cap$98.196B
P/E Ratio12.567
Dividend Yield4.950%
ExchangeNYSE
RSI
32
Short Interest
1.73%
Days to Cover2.66

Recent News

Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity.
Vandana Singh
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE:
Upwallstreet
Bristol Myers Squibb's Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation
Bristol Myers Squibb's latest data on Krazati (adagrasib) in combination with cetuximab for KRASG12C-mutated colorectal cancer. Promising objective response rates and progression-free survival. FDA priority review underway.
Vandana Singh
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
4
1
Oct 23
2
Nov 23
1
Dec 23
1
Jan
2
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.3
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Bristol-Myers Squibb Co.
Sector
Health Care
Industry
Pharmaceuticals
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as c...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BMY
NVO

FAQ

Q

How do I buy Bristol-Myers Squibb (BMY) stock?

A

You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Bristol-Myers Squibb's (BMY) competitors?

A

Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Bristol-Myers Squibb (BMY) stock?

A

The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Wells Fargo on Tuesday, February 6, 2024. The analyst firm set a price target for 51.00 expecting BMY to rise to within 12 months (a possible 5.26% upside). 35 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Bristol-Myers Squibb (BMY)?

A

The stock price for Bristol-Myers Squibb (NYSE: BMY) is $48.45 last updated Today at April 16, 2024 at 10:48 AM EDT.

Q

Does Bristol-Myers Squibb (BMY) pay a dividend?

A

A quarterly cash dividend of $0.60 per share of Class A Common Stock. The quarterly cash dividend was payable on May 1, 2024 to stockholders of record on April 4, 2024.

Q

When is Bristol-Myers Squibb (NYSE:BMY) reporting earnings?

A

Bristol-Myers Squibb’s Q1 earnings are confirmed for Thursday, April 25, 2024.

Q

Is Bristol-Myers Squibb (BMY) going to split?

A

There is no upcoming split for Bristol-Myers Squibb.

Q

What sector and industry does Bristol-Myers Squibb (BMY) operate in?

A

Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch